Clindamycin Injection USP in 5% Dextrose recall: CGMP Deviations
Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured…
Why was Clindamycin Injection USP in 5% Dextrose recalled?
CGMP Deviations
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # NC194068, Exp Date: 10/29/2027.
- Product
- Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured…
- Recalling firm
- Baxter Healthcare Corporation
- Quantity
- N/A
- Distribution
- US Nationwide; Puerto Rico; and Chile.
- Recall date
- September 9, 2026
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)